3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
34
Colonic Neoplasms
18
Rectal Neoplasms
14
Pancreatic Neoplasms
8
Esophageal Neoplasms
7
Adenomatous Polyposis Coli
7
Liver Neoplasms
5
Carcinoma, Hepatocellular
4
Neoplasm Metastasis
3
Turcot syndrome
2
Thymoma
2
Neoplasms
2
Lung Neoplasms
2
Locally Advanced Rectal Cancer
2
Hand-Foot Syndrome
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Thrombocytosis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polyps
1
Pancreatic Cancer Metastatic
1
Pain, Postoperative
1
Interventions
pembrolizumab
5
Nivolumab
5
Ipilimumab
4
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
durvalumab
2
atezolizumab
2
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Celecoxib
2
tislelizumab
1
spartalizumab
1
sintilimab
1
regorafenib
1
fludarabine phosphate
1
fludarabine
1
danvatirsen
1
camrelizumab
1
Taxes
1
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Interleukin-2
1
Immunoglobulin G
1
IMM-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Turcot syndrome
×
Celecoxib
×
Gastrointestinal
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled